Health problems in survivors of childhood cancer;Gezondheidsproblemen na de behandeling van kinderkanker

Tijdschrift voor Kindergeneeskunde

Volumn 74, Issue 6, 2006, Pages 209-214

  Postma, A ^a   Schouten Van Meeteren, A Y N ^b   Hakvoort Cammel, F G A J ^c   Bresters, D ^d   Versluys, A B ^e   Bokkerink J P M ^f   Van Dulmen Den Broeder, E ^g   Van Der Pal, H J H ^b   Van Dam, E W C M ^g   Van Der Linden, G H M ^c   Blaauwbroek, R ^a   Van Leeuwen, F E ^h   Jaspers, M W M ⁱ   Kremer, L C M ^b   Van Den Bos, C ^b  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b EMMA CHILDREN S HOSPITAL   (Netherlands)

^c SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^e UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^f RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^g VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^h ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

ⁱ ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE DERIVATIVE; ANTINEOPLASTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ARTICLE; CANCER CENTER; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RISK; CANCER SURVIVAL; CHILDHOOD CANCER; DIAGNOSTIC TEST; HEALTH STATUS; HUMAN; NETHERLANDS; PATIENT CARE; SCREENING TEST;

EID: 33846576739     PISSN: 03767442     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Curry HL, Parkes SE, Powell JE, et al. Caring for survivors of childhood cancer: The size of the problem. Eur J Cancer. 2006;42:501-8.
2. Hewitt MWS, Simone JV, eds. Childhood cancer survivorship: improving care and quality of life. Washington: National Academic Press, 2003.
3. Meadows AT, Krejmas NL, Belasco JB. The medical cost of cure: sequelae in survivors of childhood cancer. In: Eys J van, Sullivan MP, eds. Status of the curability of childhood cancers. New York: Raven Press, 1980.
4. Postma A, Berendt H, Groot-Loonen JJ, et al. Iatrogene gevolgen van kanker op de kinderleeftijd. Tijdschr Kindergeneeskd. 1999;5:219-23.
5. Mertens AC, Yasui Y, Neglia JP, et al. Late mortality experience in five-year survivors of childhood and adolescent cancer: the Childhood Cancer Survivor Study. J Clin Oncol. 2001;19:3163-72.
6. Möller TR, Garwicz S, Barlow L, et al. Decreasing late mortality among five-year survivors of cancer in childhood and adolescence: a population-based study in the Nordic countries. J Clin Oncol. 2001;19:3173-81.
7. Wallace WH, Green DM. Late effects of childhood cancer. London: Arnold, 2004.
8. Schwartz CL, Hobbie WL, Constine LS, Ruccione KS. Survivors of childhood and adolescent cancer; a multidisciplinary approach. Berlin: Springer, 2005.
9. Grenier MA, Lipschultz SE. Epidemiology of anthracycline cardiotoxicity in children and adults. Semin Oncol. 1998;25 (suppl):72-85.
10. Kremer LC, Dalen EC van, Offringa M, et al. Anthracycline-induced clinical heart failure in a cohort of 607 children: long-term follow-up study. J Clin Oncol. 2001;19:191-6.
11. Lipshultz SE, Colan SD, Gelber RD, et al. Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood. N Engl J Med. 1991;324:808-15.
12. Silber JH, Cnaan A, Clark BJ, et al. Enalapril to prevent cardiac function decline in long-term survivors of pediatric cancer exposed to anthracyclines. J Clin Oncol. 2002;22:820-8.
13. Adams MJ, Hardenberg PH, Constine LS, Lipshultz SE. Radiation-associated cardiovascular disease. Crit Rev Oncol Hematol. 2003;45:55-75.
14. Reinders JG, Heijmen BJ, Olofsen-van Acht MJ, et al. Ischemic heart disease after mantlefield irradiation of Hodgkin's disease in long-term follow-up. Radiother Oncol. 1999;51:35-42.
15. Neglia JP, Griedman DL, Yasu Y, et al. Second malignant neoplasms in five-year survivors of childhood cancer: childhood cancer survivor study. J Nat Cancer Inst. 2001;93:618-29.
16. Walter AW, Hancock ML, Pui CH, et al. Secondary brain tumors in children treated for acute lymphoblastic leukemia at St Jude Children's Research Hospital. J Clin Oncol. 1998;16:3761-7.
17. Bhatia S, Yasiu Y, Robison LL. High risk of subsequent neoplasms continues with extended follow-up of childhood Hodgkin's disease: report from the late effects study group. J Clin Oncol. 2003;21:4386-94.
18. Lai R, Crevier L, Thabane L. Genetic polymorphisms of glutathione S-transferases and the risk of adult brain tumor: a meta-analysis. Cancer Epidemiol Biomarkers Prev. 2005;14:1784-90.
19. Landier W, Wallace WHB, Hudson MM. Long-term follow-up of pediatric cancer survivors: education, surveillance, and screening. Pediatr Blood Cancer. 2006;46:149-58.
20. Wallace WHB, Blacklay A, Eiser C, et al. Developing strategies for long term follow up of survivors of childhood cancer. BMJ. 2001;323:271-4.
21. Goldsby RE, Ablin AR. Surviving childhood cancer; now what? Controversies regarding long-term follow-up. Pediatr Blood Cancer. 2004;43:211-4.
22. Bhatia S, Meadows AT. Long-term follow-up of childhood cancer survivors: future directions for clinical care and research. Pediatr Blood Cancer. 2006;46:143-8.
23. Friedman DL, Freyer DR, Levitt GA. Models of care for survivors of childhood cancer. Pediatr Blood Cancer. 2006;46:159-68.
24. Jaspers MWM, Bos C van den, Keinen RC, et al. Development of a national protocol to screen Dutch cancer survivors on late cancer treatment effects. Int J Med Inform. 2006 Mar 11; [Epub ahead of print].
25. Kremer LCM, Jaspers MWM, Leeuwen FE van, et al. Landelijke richtlijnen voor follow-up van overlevenden van kinderkanker. Tijdschr Kindergeneeskd. 2006;74:214-8.
26. Oeffinger KC, Wallace WHB. Barriers to follow-up care of survivors in the United States and the United Kingdom. Pediatr Blood Cancer. 2006;46:135-42.
27. Hawkins MM, Robison LL. Importance of clinical and epidemiological research in defining the long-term clinical care of pediatric cancer survivors. Pediatr Blood Cancer. 2006;46:174-8.